REGULATORY INTELLIGENCE·Recall
Class I Recall: Accord BioPharma's UDENYCA (Pegfilgrastim-cbqv) Impacted by Temperature Abuse
McKesson has initiated a Class I recall for Accord BioPharma's UDENYCA (pegfilgrastim-cbqv) injection due to temperature abuse, affecting 116 cartons nationwide. This event highlights critical vulnerabilities in pharmaceutical cold chain logistics, posing significant risks to patient safety and demanding immediate strategic review by procurement and supply chain leaders to safeguard product integrity and market confidence.
90-Day Activity